Search results
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 2 hours agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 2 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 2 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 34 minutes agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
2 Biotech Stocks to Buy in May | The Motley Fool
The Motley Fool· 6 days agoThe stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that...
CAC 40 Struggles For Direction As Inflation Accelerates
RTT News· 7 hours agoFrench stocks struggled for direction on Friday after data showed consumer prices in the country rose at a faster rate this month due to higher energy prices. Consumer prices rose an average ...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Sanofi’s CEO thinks OpenAI offers 'insane' potential for thepharmaceutical industry
Fortune· 2 days agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. Last week, Hudson proudly announced his company’s new partnership ...
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 6 days agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...